These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 22300092)

  • 1. The dark side of pharmaceutical chemistry.
    Westwell AD; Caldicott DG; Hutchings A
    Future Med Chem; 2012 Feb; 4(2):129-32. PubMed ID: 22300092
    [No Abstract]   [Full Text] [Related]  

  • 2. [The biochemical basis of pharmaceutical chemistry. 9. The effect of structure on biopharmaceutic/pharmacokinetic behavior].
    Nuhn P; Neubert R
    Pharmazie; 1991 Jan; 46(1):61-72. PubMed ID: 1857735
    [No Abstract]   [Full Text] [Related]  

  • 3. [Relationship between chemical structure and pharmacodynamic activity].
    Tronchet JM
    Pharm Acta Helv; 1973; 48(8):482-8. PubMed ID: 4766789
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of a logical procedure in searching for a relationship between the chemical structure of substances and their biological activity].
    Waisser K
    Cesk Farm; 1990 Jun; 39(4):188-91. PubMed ID: 2393915
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of methods of differentiating between arrangements in chemical structure and biological activity relationships].
    Rejholec V; Kuchar M
    Cesk Farm; 1980 Nov; 29(8-9):315-20. PubMed ID: 7460036
    [No Abstract]   [Full Text] [Related]  

  • 6. Structure-activity relationships on quantum-chemical basis.
    Sklenar H; Jäger J
    Pharmazie; 1981 May; 36(5):388. PubMed ID: 7267694
    [No Abstract]   [Full Text] [Related]  

  • 7. A sorcerer's apprentice and The Rule of Five: from rule-of-thumb to commandment and beyond.
    Abad-Zapatero C
    Drug Discov Today; 2007 Dec; 12(23-24):995-7. PubMed ID: 18061876
    [No Abstract]   [Full Text] [Related]  

  • 8. SARVision Plus.
    Reichard GA
    J Chem Inf Model; 2008 Jun; 48(6):1287-8. PubMed ID: 18528997
    [No Abstract]   [Full Text] [Related]  

  • 9. Safer chemicals through molecular design. Symposium. Arlington, Virginia, September 11-15, 1983.
    Drug Metab Rev; 1984; 15(5-6):873-1159. PubMed ID: 6525964
    [No Abstract]   [Full Text] [Related]  

  • 10. Trends in searching for antitumor compounds.
    Preobrazhenskaya MN
    Natl Cancer Inst Monogr; 1977 Mar; (45):195-205. PubMed ID: 337151
    [No Abstract]   [Full Text] [Related]  

  • 11. Assessment of quantum mechanical techniques for use in structure activity relationship development, and application to analgesics and other drugs.
    Cheney BV; Duchamp DJ; Christoffersen RE
    NIDA Res Monogr; 1978; (22):218-49. PubMed ID: 30908
    [No Abstract]   [Full Text] [Related]  

  • 12. Application of pharmaceutical profiling assays for optimization of drug-like properties.
    Di L; Kerns EH
    Curr Opin Drug Discov Devel; 2005 Jul; 8(4):495-504. PubMed ID: 16022186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Navigating structure-activity landscapes.
    Bajorath J; Peltason L; Wawer M; Guha R; Lajiness MS; Van Drie JH
    Drug Discov Today; 2009 Jul; 14(13-14):698-705. PubMed ID: 19410012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cheminformatic tools for medicinal chemists.
    Muchmore SW; Edmunds JJ; Stewart KD; Hajduk PJ
    J Med Chem; 2010 Jul; 53(13):4830-41. PubMed ID: 20329801
    [No Abstract]   [Full Text] [Related]  

  • 15. From magic bullets to designed multiple ligands.
    Morphy R; Kay C; Rankovic Z
    Drug Discov Today; 2004 Aug; 9(15):641-51. PubMed ID: 15279847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationships of triazolopyridine oxazole p38 inhibitors: identification of candidates for clinical development.
    McClure KF; Letavic MA; Kalgutkar AS; Gabel CA; Audoly L; Barberia JT; Braganza JF; Carter D; Carty TJ; Cortina SR; Dombroski MA; Donahue KM; Elliott NC; Gibbons CP; Jordan CK; Kuperman AV; Labasi JM; Laliberte RE; McCoy JM; Naiman BM; Nelson KL; Nguyen HT; Peese KM; Sweeney FJ; Taylor TJ; Trebino CE; Abramov YA; Laird ER; Volberg WA; Zhou J; Bach J; Lombardo F
    Bioorg Med Chem Lett; 2006 Aug; 16(16):4339-44. PubMed ID: 16759861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. QSAR: a critical appraisal.
    Archer S
    NIDA Res Monogr; 1978; (22):86-102. PubMed ID: 30914
    [No Abstract]   [Full Text] [Related]  

  • 18. Structure-activity relationship homology (SARAH): a conceptual framework for drug discovery in the genomic era.
    Frye SV
    Chem Biol; 1999 Jan; 6(1):R3-7. PubMed ID: 9889153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationship studies of the chromosome segregation inhibitor, Incentrom A.
    Lee HY; Jung Y; Kim W; Kim JH; Suh MS; Shin SK; Yoon HJ
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4670-4. PubMed ID: 18656350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medicinal chemistry endeavors around the phytocannabinoids.
    Stern E; Lambert DM
    Chem Biodivers; 2007 Aug; 4(8):1707-28. PubMed ID: 17712816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.